Daniel Schauer

Daniel Schauer has conducted comprehensive systematic reviews and meta-analyses quantifying the cancer risk reduction associated with bariatric surgery, providing the pooled estimates that inform clinical guidelines and health policy decisions. His evidence synthesis work has identified specific cancer types most strongly associated with surgical weight loss benefit, including endometrial, breast, and colorectal cancers. He contributes to evidence-based guideline development for metabolic surgery indications.